Biomarkers for immunotherapy: Results from the analysis of a HLA-A-status double-blind, biologically-randomized phase II study of five therapeutic epitope-peptides with oxaliplatin-based chemotherapy as first-line therapy for advanced colorectal cancer (F

Shoichi Hazama
Yusuke Nakamura
Hiroaki Tanaka
Fumiaki Sugiura
Kiyotaka Okuno
Kazuhiko Yoshimatsu
Hiroko Takenouchi
Ryouichi Tsunedomi
Yuka Inoue
Shinsuke Kanekiyo
Yoshitaro Shindo
Kiyoshi Yoshimura
Shigefumi Yoshino
Tomonobu Fujita
Yutaka Kawakami
Masaaki Oka

第18回日本がん免疫学会総会

愛媛